Sherif Wagdy Ayad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sherif Wagdy Ayad has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Michael Y. Henein
National Heart and Lung Institute, Imperial College, London SW3 6LY, UK
4 shared publications - Ahmed Mahmoud El Amrawy
Cardiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
3 shared publications - Federico Vancheri
Department of Internal Medicine, S. Elia Hospital, 93100 Caltanissetta, Italy
2 shared publications - Ibadete Bytyçi
Clinic of Cardiology, University Clinical Centre of Kosovo, Prishtina, Kosovo
2 shared publications - Matteo Cameli
Department of Medical Biotechnologies, Division of Cardiology, University of Siena, 53100 Siena, Italy
2 shared publications Mohamed A. Sobhy
2 shared publications
Latest Publications
- Open Access
- 25 October 2024
- Published by Springer Nature in Cardiology and Therapy
- Vol. 13 (4) , 707-736
ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation
Introduction The renin–angiotensin–aldosterone system (RAAS) plays a pivotal role in regulating blood pressure (BP), with dysregulation of RAAS resulting in hypertension and potentially heart failure (HF), myocardial infarction (MI), cardio-renal syndrome, and stroke. RAAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs), have advantages beyond BP control. However, differences between these two drug classes need to be considered when choosing a therapy for preventing cardiovascular events. Methods A panel of 36 Egyptian cardiologists developed consensus statements on RAAS inhibitors for primary and secondary prevention of cardiovascular outcomes and stroke, using a modified three-step Delphi process. Results The consensus statements highlight the importance of effective BP control and the role of RAAS blockade for prevention and management of various cardiovascular diseases. ACEis and ARBs differ in their mode of action and, thus, clinical effects. On the basis of available evidence, the consensus group recommended the following: ACEis should be considered as first choice (in preference to ARBs) to reduce the risk of MI, for primary prevention of HF, and for secondary prevention of stroke. ACEis and ARBs show equivalent efficacy for the primary prevention of stroke. Evidence also favors the preferential use of ACEis in patients with type 2 diabetes, for BP control, for the primary prevention of diabetic kidney disease, and to reduce the risk of major cardiovascular and renal outcomes. Treatment with an ACEi should be started within 24 h of ST segment elevation MI (and continued long term) in patients with HF, left ventricular systolic dysfunction, and/or diabetes. Angiotensin receptor/neprilysin inhibitors (ARNIs) are the first choice for patients with HF and reduced ejection fraction, with ACEis being the second choice in this group. ARBs are indicated as alternatives in patients who cannot tolerate ACEis. ACEis may be associated with cough development, but the incidence tends to be overestimated, and the risk can be reduced by use of a lipophilic ACEi or combining the ACEi with a calcium channel blocker. Conclusion RAAS blockade is an essential component of hypertension therapy; however, the protective effects provided by ACEis are superior to those of ARBs. Therefore, an ACEi is indicated in almost all cases, unless not tolerated.
- 25 October 2024
- Published by Springer Nature in Cardiology and Therapy
- Vol. 13 (4) , 707-736
Open AccessACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation
Introduction The renin–angiotensin–aldosterone system (RAAS) plays a pivotal role in regulating blood pressure (BP), with dysregulation of RAAS resulting in hypertension and potentially heart failure (HF), myocardial infarction (MI), cardio-renal syndrome, and stroke. RAAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs), have advantages beyond BP control. However, differences between these two drug classes need to be considered when choosing a therapy for preventing cardiovascular events. Methods A panel of 36 Egyptian cardiologists developed consensus statements on RAAS inhibitors for primary and secondary prevention of cardiovascular outcomes and stroke, using a modified three-step Delphi process. Results The consensus statements highlight the importance of effective BP control and the role of RAAS blockade for prevention and management of various cardiovascular diseases. ACEis and ARBs differ in their mode of action and, thus, clinical effects. On the basis of available evidence, the consensus group recommended the following: ACEis should be considered as first choice (in preference to ARBs) to reduce the risk of MI, for primary prevention of HF, and for secondary prevention of stroke. ACEis and ARBs show equivalent efficacy for the primary prevention of stroke. Evidence also favors the preferential use of ACEis in patients with type 2 diabetes, for BP control, for the primary prevention of diabetic kidney disease, and to reduce the risk of major cardiovascular and renal outcomes. Treatment with an ACEi should be started within 24 h of ST segment elevation MI (and continued long term) in patients with HF, left ventricular systolic dysfunction, and/or diabetes. Angiotensin receptor/neprilysin inhibitors (ARNIs) are the first choice for patients with HF and reduced ejection fraction, with ACEis being the second choice in this group. ARBs are indicated as alternatives in patients who cannot tolerate ACEis. ACEis may be associated with cough development, but the incidence tends to be overestimated, and the risk can be reduced by use of a lipophilic ACEi or combining the ACEi with a calcium channel blocker. Conclusion RAAS blockade is an essential component of hypertension therapy; however, the protective effects provided by ACEis are superior to those of ARBs. Therefore, an ACEi is indicated in almost all cases, unless not tolerated.
- 1 July 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (7) , 453-457
Right ventricular dysfunction as a predictor of mortality in patients with sepsis or septic shock in the emergency department
Aim Sepsis and septic shock present a significant challenge in the emergency department (ED) owing to their high mortality rates. The presence of right ventricle (RV) dysfunction during sepsis could potentially exacerbate unfavorable outcomes. However, the precise relationship between RV dysfunction and mortality in septic patients remains poorly understood. Therefore, this study aims to investigate the prognostic value of RV dysfunction as a predictor of mortality in patients presenting with sepsis or septic shock in the ED of Alexandria main university hospital. Methods A prospective observational study was performed on 75 patients who presented to the ED with sepsis or septic shock. Echocardiographic parameters, including the tricuspid annulus systolic plane excursion (TAPSE) and the fractional area change, were measured within 24 hours after admission for assessment of RV dysfunction; then, patients were evaluated according to sequential organ failure score (SOFA) and acute physiologic and chronic health assessment (APACHE). Using multivariate regression, the current study assessed the relationship between 28-day mortality and the presence of RV dysfunction, SOFA, and APACHE. Results There were 75 patients in the study. 22 patients (29%) had RV dysfunction. When compared to patients without RV dysfunction, those with RV dysfunction had a greater mortality rate (68% vs. 34%, P < .001). RV dysfunction was shown to be associated with mortality in univariate regression analysis (OR:4.16, CI:1.44-12, P < .008), and multivariable regression analysis revealed a high correlation between RV dysfunction and mortality (OR:3.98, CI:1.3-11.9, P < .013). With a statistically significant area under the curve, sensitivity, specificity, positive predictive value, and negative predictive value of 0.64, 45.5, 83.8, 68.2, and 66%, respectively, the receiver operator curve (ROC) indicated that RV dysfunction was linked to a considerable mortality rate. Conclusion RV dysfunction was found in nearly one-third of the studied patients with sepsis and is associated with fourfold higher 28-day mortality.
- 1 July 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (7) , 453-457
Right ventricular dysfunction as a predictor of mortality in patients with sepsis or septic shock in the emergency department
Aim Sepsis and septic shock present a significant challenge in the emergency department (ED) owing to their high mortality rates. The presence of right ventricle (RV) dysfunction during sepsis could potentially exacerbate unfavorable outcomes. However, the precise relationship between RV dysfunction and mortality in septic patients remains poorly understood. Therefore, this study aims to investigate the prognostic value of RV dysfunction as a predictor of mortality in patients presenting with sepsis or septic shock in the ED of Alexandria main university hospital. Methods A prospective observational study was performed on 75 patients who presented to the ED with sepsis or septic shock. Echocardiographic parameters, including the tricuspid annulus systolic plane excursion (TAPSE) and the fractional area change, were measured within 24 hours after admission for assessment of RV dysfunction; then, patients were evaluated according to sequential organ failure score (SOFA) and acute physiologic and chronic health assessment (APACHE). Using multivariate regression, the current study assessed the relationship between 28-day mortality and the presence of RV dysfunction, SOFA, and APACHE. Results There were 75 patients in the study. 22 patients (29%) had RV dysfunction. When compared to patients without RV dysfunction, those with RV dysfunction had a greater mortality rate (68% vs. 34%, P < .001). RV dysfunction was shown to be associated with mortality in univariate regression analysis (OR:4.16, CI:1.44-12, P < .008), and multivariable regression analysis revealed a high correlation between RV dysfunction and mortality (OR:3.98, CI:1.3-11.9, P < .013). With a statistically significant area under the curve, sensitivity, specificity, positive predictive value, and negative predictive value of 0.64, 45.5, 83.8, 68.2, and 66%, respectively, the receiver operator curve (ROC) indicated that RV dysfunction was linked to a considerable mortality rate. Conclusion RV dysfunction was found in nearly one-third of the studied patients with sepsis and is associated with fourfold higher 28-day mortality.
- Open Access
- 1 December 2023
- Published by Egyptian Knowledge Bank in Alexandria Dental Journal
- Vol. 48 (3) , 1-7
COMPARISON OF SOCKET PRESERVATION USING SOCKET SHIELD TECHNIQUE WITH AUTOGENOUS DENTIN GRAFT VERSUS ALLOPLAST GRAFT MATERIAL (CLINICAL STUDY)
Background: After extracting teeth, both remarkable resorption in the alveolar bone and an obvious reduction have occurred in the labial bone plate as a consequence of the blood supply deficiency that happens especially when the periodontal ligaments are lost. Therefore, to keep the periodontal ligaments preserved, a socket shield technique with autogenous dentine was introduced.Aim of this study: Radiographic evaluation of a combined technique using autogenous dentin graft with socket shield for pre-implant socket preservationPatient and method: Eight patients received socket preservation using alloplast with socket shield on one side and received socket preservation using Autogenous dentin graft with socket shield on the contralateral side (split-mouth Design). CBCT was done before surgery and after 3 months to evaluate bone density and bone height.Result: The density of the recently formed teeth bone was significantly greater in the study group participants (P=0.011) than in the control one. However, when comparing its height among the 2 groups, there was no significant difference that could be considered.Conclusion: Autogenous Dentin proved to be a promising graft together with using the socket shield protection approach that helped in preserving the socket, especially in the esthetic zone. Therefore, further clinical studies could be performed to compare autogenous dentin and other bone substitutes.
- 1 December 2023
- Published by Egyptian Knowledge Bank in Alexandria Dental Journal
- Vol. 48 (3) , 1-7
Open AccessCOMPARISON OF SOCKET PRESERVATION USING SOCKET SHIELD TECHNIQUE WITH AUTOGENOUS DENTIN GRAFT VERSUS ALLOPLAST GRAFT MATERIAL (CLINICAL STUDY)
Background: After extracting teeth, both remarkable resorption in the alveolar bone and an obvious reduction have occurred in the labial bone plate as a consequence of the blood supply deficiency that happens especially when the periodontal ligaments are lost. Therefore, to keep the periodontal ligaments preserved, a socket shield technique with autogenous dentine was introduced.Aim of this study: Radiographic evaluation of a combined technique using autogenous dentin graft with socket shield for pre-implant socket preservationPatient and method: Eight patients received socket preservation using alloplast with socket shield on one side and received socket preservation using Autogenous dentin graft with socket shield on the contralateral side (split-mouth Design). CBCT was done before surgery and after 3 months to evaluate bone density and bone height.Result: The density of the recently formed teeth bone was significantly greater in the study group participants (P=0.011) than in the control one. However, when comparing its height among the 2 groups, there was no significant difference that could be considered.Conclusion: Autogenous Dentin proved to be a promising graft together with using the socket shield protection approach that helped in preserving the socket, especially in the esthetic zone. Therefore, further clinical studies could be performed to compare autogenous dentin and other bone substitutes.
- 8 August 2022
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 40, 30
Procedural and Long-Term Outcomes of Stent Post-Dilatation During Primary Percutaneous Coronary Interventions
- 8 August 2022
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 40, 30
Procedural and Long-Term Outcomes of Stent Post-Dilatation During Primary Percutaneous Coronary Interventions
- 8 August 2022
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 40, 80
Impact of Cardiac Rehabilitation on Patients With Heart Failure With Preserved Ejection Fraction
- 8 August 2022
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 40, 80
Impact of Cardiac Rehabilitation on Patients With Heart Failure With Preserved Ejection Fraction
- 24 November 2021
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 33 (12) , E960-E967
Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease
The study goal was to assess the feasibility and short-term clinical outcomes of implanting 48 mm drug-eluting stents (DESs) for the treatment of long lesions in patients with coronary artery disease (CAD).
- 24 November 2021
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 33 (12) , E960-E967
Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease
The study goal was to assess the feasibility and short-term clinical outcomes of implanting 48 mm drug-eluting stents (DESs) for the treatment of long lesions in patients with coronary artery disease (CAD).
- Open Access
- 1 July 2021
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 28, S48-S49
The Impact of COVID-19 on In-Hospital Outcomes of ST-Segment Elevation Myocardial Infarction Patients
- 1 July 2021
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 28, S48-S49
Open AccessThe Impact of COVID-19 on In-Hospital Outcomes of ST-Segment Elevation Myocardial Infarction Patients
- Open Access
- 22 June 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (13) , 2752
Obesity Strongly Predicts COVID-19-Related Major Clinical Adverse Events in Coptic Clergy
Background and Aims: The Coptic clergy, due to their specific work involving interaction with many people, could be subjected to increased risk of infection from COVID-19. The aim of this study, a sub-study of the COVID-19-CVD international study of the impact of the pandemic on the cardiovascular system, was to assess the prevalence of COVID-19 among Coptic priests and to identify predictors of clinical adverse events. Methods: Participants were geographically divided into three groups: Group-I: Europe and USA, Group II: Northern Egypt, and Group III: Southern Egypt. Participants’ demographic indices, cardiovascular risk factors, possible source of infection, number of liturgies, infection management, and major adverse events (MAEs), comprising death, or mechanical ventilation, were assessed. Results: Out of the 1570 clergy serving in 25 dioceses, 255 (16.2%) were infected. Their mean age was 49.5 ± 12 years and mean weekly number of liturgies was 3.44 ± 1.0. The overall prevalence rate was 16.2% and did not differ between Egypt as a whole and overseas (p = 0.23). Disease prevalence was higher in Northern Egypt clergy compared with Europe and USA combined (18.4% vs. 12.1%, p = 0.03) and tended to be higher than in Southern Egypt (18.4% vs. 13.6%, p = 0.09). Ten priests (3.92%) died of COVID-19-related complications, and 26 (10.2) suffered a MAE. The clergy from Southern Egypt were more obese, but the remaining risk factors were less prevalent compared with those in Europe and USA (p = 0.01). In multivariate analysis, obesity (OR = 4.180; 2.479 to 12.15; p = 0.01), age (OR = 1.055; 0.024 to 1.141; p = 0.02), and systemic hypertension (OR = 1.931; 1.169 to 2.004; p = 0.007) predicted MAEs. Obesity was the most powerful independent predictor of MAE in Southern Egypt and systemic hypertension in Northern Egypt (p < 0.05 for both). Conclusion: Obesity is very prevalent among Coptic clergy and seems to be the most powerful independent predictor of major COVID-19-related adverse events. Coptic clergy should be encouraged to follow the WHO recommendations for cardiovascular disease and COVID-19 prevention.
- 22 June 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (13) , 2752
Open AccessObesity Strongly Predicts COVID-19-Related Major Clinical Adverse Events in Coptic Clergy
Background and Aims: The Coptic clergy, due to their specific work involving interaction with many people, could be subjected to increased risk of infection from COVID-19. The aim of this study, a sub-study of the COVID-19-CVD international study of the impact of the pandemic on the cardiovascular system, was to assess the prevalence of COVID-19 among Coptic priests and to identify predictors of clinical adverse events. Methods: Participants were geographically divided into three groups: Group-I: Europe and USA, Group II: Northern Egypt, and Group III: Southern Egypt. Participants’ demographic indices, cardiovascular risk factors, possible source of infection, number of liturgies, infection management, and major adverse events (MAEs), comprising death, or mechanical ventilation, were assessed. Results: Out of the 1570 clergy serving in 25 dioceses, 255 (16.2%) were infected. Their mean age was 49.5 ± 12 years and mean weekly number of liturgies was 3.44 ± 1.0. The overall prevalence rate was 16.2% and did not differ between Egypt as a whole and overseas (p = 0.23). Disease prevalence was higher in Northern Egypt clergy compared with Europe and USA combined (18.4% vs. 12.1%, p = 0.03) and tended to be higher than in Southern Egypt (18.4% vs. 13.6%, p = 0.09). Ten priests (3.92%) died of COVID-19-related complications, and 26 (10.2) suffered a MAE. The clergy from Southern Egypt were more obese, but the remaining risk factors were less prevalent compared with those in Europe and USA (p = 0.01). In multivariate analysis, obesity (OR = 4.180; 2.479 to 12.15; p = 0.01), age (OR = 1.055; 0.024 to 1.141; p = 0.02), and systemic hypertension (OR = 1.931; 1.169 to 2.004; p = 0.007) predicted MAEs. Obesity was the most powerful independent predictor of MAE in Southern Egypt and systemic hypertension in Northern Egypt (p < 0.05 for both). Conclusion: Obesity is very prevalent among Coptic clergy and seems to be the most powerful independent predictor of major COVID-19-related adverse events. Coptic clergy should be encouraged to follow the WHO recommendations for cardiovascular disease and COVID-19 prevention.
- Open Access
- 12 May 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (10) , 2066
Combined Cardiac Risk Factors Predict COVID-19 Related Mortality and the Need for Mechanical Ventilation in Coptic Clergy
Background and Aims: The clinical adverse events of COVID-19 among clergy worldwide have been found to be higher than among ordinary communities, probably because of the nature of their work. The aim of this study was to assess the impact of cardiac risk factors on COVID-19-related mortality and the need for mechanical ventilation in Coptic clergy. Methods: Of 1570 Coptic clergy participating in the COVID-19-Clergy study, serving in Egypt, USA and Europe, 213 had the infection and were included in this analysis. Based on the presence of systemic arterial hypertension (AH), participants were divided into two groups: Group-I, clergy with AH (n = 77) and Group-II, without AH (n = 136). Participants’ demographic indices, cardiovascular risk factors, COVID-19 management details and related mortality were assessed. Results: Clergy with AH were older (p < 0.001), more obese (p = 0.04), had frequent type 2 diabetes (DM) (p = 0.001), dyslipidemia (p = 0.001) and coronary heart disease (CHD) (p = 0.04) compared to those without AH. COVID-19 treatment at home, hospital or in intensive care did not differ between the patient groups (p > 0.05 for all). Clergy serving in Northern and Southern Egypt had a higher mortality rate compared to those from Europe and the USA combined (5.22%, 6.38%, 0%; p = 0.001). The impact of AH on mortality was significant only in Southern Egypt (10% vs. 3.7%; p = 0.01) but not in Northern Egypt (4.88% vs. 5.81%; p = 0.43). In multivariate analysis, CHD OR 1.607 ((0.982 to 3.051); p = 0.02) and obesity, OR 3.403 ((1.902 to 4.694); p = 0.04) predicted COVID-19 related mortality. A model combining cardiac risk factors (systolic blood pressure (SBP) ≥ 160 mmHg, DM, obesity and history of CHD) was the most powerful independent predictor of COVID-19-related mortality, OR 3.991 ((1.919 to 6.844); p = 0.002). Almost the same model also proved the best independent multivariate predictor of mechanical ventilation OR 1.501 ((0.809 to 6.108); p = 0.001). Conclusion: In Coptic clergy, the cumulative impact of risk factors was the most powerful predictor of mortality and the need for mechanical ventilation.
- 12 May 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (10) , 2066
Open AccessCombined Cardiac Risk Factors Predict COVID-19 Related Mortality and the Need for Mechanical Ventilation in Coptic Clergy
Background and Aims: The clinical adverse events of COVID-19 among clergy worldwide have been found to be higher than among ordinary communities, probably because of the nature of their work. The aim of this study was to assess the impact of cardiac risk factors on COVID-19-related mortality and the need for mechanical ventilation in Coptic clergy. Methods: Of 1570 Coptic clergy participating in the COVID-19-Clergy study, serving in Egypt, USA and Europe, 213 had the infection and were included in this analysis. Based on the presence of systemic arterial hypertension (AH), participants were divided into two groups: Group-I, clergy with AH (n = 77) and Group-II, without AH (n = 136). Participants’ demographic indices, cardiovascular risk factors, COVID-19 management details and related mortality were assessed. Results: Clergy with AH were older (p < 0.001), more obese (p = 0.04), had frequent type 2 diabetes (DM) (p = 0.001), dyslipidemia (p = 0.001) and coronary heart disease (CHD) (p = 0.04) compared to those without AH. COVID-19 treatment at home, hospital or in intensive care did not differ between the patient groups (p > 0.05 for all). Clergy serving in Northern and Southern Egypt had a higher mortality rate compared to those from Europe and the USA combined (5.22%, 6.38%, 0%; p = 0.001). The impact of AH on mortality was significant only in Southern Egypt (10% vs. 3.7%; p = 0.01) but not in Northern Egypt (4.88% vs. 5.81%; p = 0.43). In multivariate analysis, CHD OR 1.607 ((0.982 to 3.051); p = 0.02) and obesity, OR 3.403 ((1.902 to 4.694); p = 0.04) predicted COVID-19 related mortality. A model combining cardiac risk factors (systolic blood pressure (SBP) ≥ 160 mmHg, DM, obesity and history of CHD) was the most powerful independent predictor of COVID-19-related mortality, OR 3.991 ((1.919 to 6.844); p = 0.002). Almost the same model also proved the best independent multivariate predictor of mechanical ventilation OR 1.501 ((0.809 to 6.108); p = 0.001). Conclusion: In Coptic clergy, the cumulative impact of risk factors was the most powerful predictor of mortality and the need for mechanical ventilation.
- Open Access
- 7 April 2021
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 73 (1) , 1-9
Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome
Background: Significance of totally occluded culprit coronary artery in patients presenting with non-ST segment elevation myocardial infarction (NSTEMI) is underestimated. The aim of the study was to evaluate the incidence and impact of totally occluded culprit artery on in-hospital and 6 months follow-up outcomes of NSTEMI acute coronary syndrome (ACS) patients.Results: We collected retrospectively data of 500 NSTEMI patients who presented to our hospital from June 2016 to June 2017. All patients underwent PCI within 72 h of presentation. We excluded patients with cardiogenic shock, prior CABG, and STEMI. Patients were divided into two groups according to pre-procedural culprit vessel thrombolysis in myocardial infarction (TIMI) flow. Group 1, TIMI flow 0 total coronary occlusion, included 112 patients (22.4%). Group 2, TIMI flow 1–3 non-total occlusion, included 388 patients (77.6%). Group 1 patients had significantly higher incidence of smoking (p=0.01), significantly higher level of cardiac enzymes (pppp=0.02) and significantly more LAD as the culprit vessel. There were no significant differences between the two groups regarding the major adverse cardiac and cerebrovascular events (MACCE) in-hospital (5.3% in totally occluded group vs. 1% in non-totally occluded group,p=0.07), but group 1 patients had significantly higher incidence of in-hospital arrhythmia (8.9% in group 1 vs. 1% in group 2,p=0.007). After 6 months follow-up, there were no significant differences regarding MACCE between the 2 groups after 6 months follow-up (5.4% in group 1 vs. 4.6% of group 2,P=0.24).Conclusion: 22.4% of NSTEMI patients have a totally occluded culprit artery. The presence of an occluded culprit artery did not significantly affect the clinical outcomes of NSTEMI patients either in-hospital or after 6 months follow-up but was associated with significantly higher incidence of in-hospital arrhythmia.
- 7 April 2021
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 73 (1) , 1-9
Open AccessIncidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome
Background: Significance of totally occluded culprit coronary artery in patients presenting with non-ST segment elevation myocardial infarction (NSTEMI) is underestimated. The aim of the study was to evaluate the incidence and impact of totally occluded culprit artery on in-hospital and 6 months follow-up outcomes of NSTEMI acute coronary syndrome (ACS) patients.Results: We collected retrospectively data of 500 NSTEMI patients who presented to our hospital from June 2016 to June 2017. All patients underwent PCI within 72 h of presentation. We excluded patients with cardiogenic shock, prior CABG, and STEMI. Patients were divided into two groups according to pre-procedural culprit vessel thrombolysis in myocardial infarction (TIMI) flow. Group 1, TIMI flow 0 total coronary occlusion, included 112 patients (22.4%). Group 2, TIMI flow 1–3 non-total occlusion, included 388 patients (77.6%). Group 1 patients had significantly higher incidence of smoking (p=0.01), significantly higher level of cardiac enzymes (pppp=0.02) and significantly more LAD as the culprit vessel. There were no significant differences between the two groups regarding the major adverse cardiac and cerebrovascular events (MACCE) in-hospital (5.3% in totally occluded group vs. 1% in non-totally occluded group,p=0.07), but group 1 patients had significantly higher incidence of in-hospital arrhythmia (8.9% in group 1 vs. 1% in group 2,p=0.007). After 6 months follow-up, there were no significant differences regarding MACCE between the 2 groups after 6 months follow-up (5.4% in group 1 vs. 4.6% of group 2,P=0.24).Conclusion: 22.4% of NSTEMI patients have a totally occluded culprit artery. The presence of an occluded culprit artery did not significantly affect the clinical outcomes of NSTEMI patients either in-hospital or after 6 months follow-up but was associated with significantly higher incidence of in-hospital arrhythmia.